TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory Article Swipe
Iker Ausejo‐Mauleon
,
Sara Labiano
,
Daniel de la Nava
,
Virginia Laspidea
,
Marta Zalacain
,
Lucía Marrodán
,
Marc García-Moure
,
Marisol González-Huarriz
,
Irati Hervás-Corpión
,
Laasya Dhandapani
,
Silvestre Vicent
,
María Collantes
,
Iván Peñuelas
,
Oren J. Becher
,
Mariella G. Filbin
,
Li Jiang
,
Jenna LaBelle
,
Carlos A O de Biagi-Junior
,
Javad Nazarian
,
Sandra Laternser
,
Timothy N. Phoenix
,
Jasper van der Lugt
,
Mariëtte E.G. Kranendonk
,
Raoull Hoogendijk
,
Sabine Mueller
,
Carlos de Andrea
,
Ana C. Anderson
,
Elizabeth Guruceaga
,
Carl Koschmann
,
Viveka Nand Yadav
,
Jaime Gállego Pérez‐Larraya
,
Ana Patiño-Garcı́a
,
Fernando Pastor
,
Marta M. Alonso
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1016/j.ccell.2023.09.001
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1016/j.ccell.2023.09.001
Diffuse intrinsic pontine glioma (DIPG) is an aggressive brain stem tumor and the leading cause of pediatric cancer-related death. To date, these tumors remain incurable, underscoring the need for efficacious therapies. In this study, we demonstrate that the immune checkpoint TIM-3 (HAVCR2) is highly expressed in both tumor cells and microenvironmental cells, mainly microglia and macrophages, in DIPG. We show that inhibition of TIM-3 in syngeneic models of DIPG prolongs survival and produces long-term survivors free of disease that harbor immune memory. This antitumor effect is driven by the direct effect of TIM-3 inhibition in tumor cells, the coordinated action of several immune cell populations, and the secretion of chemokines/cytokines that create a proinflammatory tumor microenvironment favoring a potent antitumor immune response. This work uncovers TIM-3 as a bona fide target in DIPG and supports its clinical translation.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.ccell.2023.09.001
- https://ars.els-cdn.com/content/image/1-s2.0-S1535610823003185-fx1_lrg.jpg
- OA Status
- hybrid
- Cited By
- 74
- References
- 60
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4387376616
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4387376616Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.ccell.2023.09.001Digital Object Identifier
- Title
-
TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memoryWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-10-05Full publication date if available
- Authors
-
Iker Ausejo‐Mauleon, Sara Labiano, Daniel de la Nava, Virginia Laspidea, Marta Zalacain, Lucía Marrodán, Marc García-Moure, Marisol González-Huarriz, Irati Hervás-Corpión, Laasya Dhandapani, Silvestre Vicent, María Collantes, Iván Peñuelas, Oren J. Becher, Mariella G. Filbin, Li Jiang, Jenna LaBelle, Carlos A O de Biagi-Junior, Javad Nazarian, Sandra Laternser, Timothy N. Phoenix, Jasper van der Lugt, Mariëtte E.G. Kranendonk, Raoull Hoogendijk, Sabine Mueller, Carlos de Andrea, Ana C. Anderson, Elizabeth Guruceaga, Carl Koschmann, Viveka Nand Yadav, Jaime Gállego Pérez‐Larraya, Ana Patiño-Garcı́a, Fernando Pastor, Marta M. AlonsoList of authors in order
- Landing page
-
https://doi.org/10.1016/j.ccell.2023.09.001Publisher landing page
- PDF URL
-
https://ars.els-cdn.com/content/image/1-s2.0-S1535610823003185-fx1_lrg.jpgDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://ars.els-cdn.com/content/image/1-s2.0-S1535610823003185-fx1_lrg.jpgDirect OA link when available
- Concepts
-
Immune system, Glioma, Tumor microenvironment, Cancer research, Microglia, Chemokine, Immune checkpoint, Proinflammatory cytokine, Biology, Blockade, Immunotherapy, Immunology, Medicine, Inflammation, Receptor, BiochemistryTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
74Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 35, 2024: 34, 2023: 5Per-year citation counts (last 5 years)
- References (count)
-
60Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4387376616 |
|---|---|
| doi | https://doi.org/10.1016/j.ccell.2023.09.001 |
| ids.doi | https://doi.org/10.1016/j.ccell.2023.09.001 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/37802053 |
| ids.openalex | https://openalex.org/W4387376616 |
| fwci | 14.35132823 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D002648 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Child |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D000080443 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Diffuse Intrinsic Pontine Glioma |
| mesh[3].qualifier_ui | Q000473 |
| mesh[3].descriptor_ui | D005910 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | pathology |
| mesh[3].descriptor_name | Glioma |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D007156 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Immunologic Memory |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D000072597 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Hepatitis A Virus Cellular Receptor 2 |
| mesh[6].qualifier_ui | Q000188 |
| mesh[6].descriptor_ui | D020295 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | drug therapy |
| mesh[6].descriptor_name | Brain Stem Neoplasms |
| mesh[7].qualifier_ui | Q000473 |
| mesh[7].descriptor_ui | D020295 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | pathology |
| mesh[7].descriptor_name | Brain Stem Neoplasms |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D059016 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Tumor Microenvironment |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D006801 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Humans |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D002648 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Child |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D000080443 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Diffuse Intrinsic Pontine Glioma |
| mesh[12].qualifier_ui | Q000473 |
| mesh[12].descriptor_ui | D005910 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | pathology |
| mesh[12].descriptor_name | Glioma |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D007156 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Immunologic Memory |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D000072597 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Hepatitis A Virus Cellular Receptor 2 |
| mesh[15].qualifier_ui | Q000188 |
| mesh[15].descriptor_ui | D020295 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | drug therapy |
| mesh[15].descriptor_name | Brain Stem Neoplasms |
| mesh[16].qualifier_ui | Q000473 |
| mesh[16].descriptor_ui | D020295 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | pathology |
| mesh[16].descriptor_name | Brain Stem Neoplasms |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D059016 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Tumor Microenvironment |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D006801 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Humans |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D002648 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Child |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D000080443 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Diffuse Intrinsic Pontine Glioma |
| mesh[21].qualifier_ui | Q000473 |
| mesh[21].descriptor_ui | D005910 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | pathology |
| mesh[21].descriptor_name | Glioma |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D007156 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Immunologic Memory |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D000072597 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Hepatitis A Virus Cellular Receptor 2 |
| mesh[24].qualifier_ui | Q000188 |
| mesh[24].descriptor_ui | D020295 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | drug therapy |
| mesh[24].descriptor_name | Brain Stem Neoplasms |
| mesh[25].qualifier_ui | Q000473 |
| mesh[25].descriptor_ui | D020295 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | pathology |
| mesh[25].descriptor_name | Brain Stem Neoplasms |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D059016 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Tumor Microenvironment |
| type | article |
| title | TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory |
| biblio.issue | 11 |
| biblio.volume | 41 |
| biblio.last_page | 1926.e8 |
| biblio.first_page | 1911 |
| topics[0].id | https://openalex.org/T12387 |
| topics[0].field.id | https://openalex.org/fields/24 |
| topics[0].field.display_name | Immunology and Microbiology |
| topics[0].score | 0.998199999332428 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2403 |
| topics[0].subfield.display_name | Immunology |
| topics[0].display_name | Galectins and Cancer Biology |
| topics[1].id | https://openalex.org/T13779 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9970999956130981 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2734 |
| topics[1].subfield.display_name | Pathology and Forensic Medicine |
| topics[1].display_name | Cancer Mechanisms and Therapy |
| topics[2].id | https://openalex.org/T10158 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.995199978351593 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Cancer Immunotherapy and Biomarkers |
| is_xpac | False |
| apc_list.value | 9080 |
| apc_list.currency | USD |
| apc_list.value_usd | 9080 |
| apc_paid.value | 9080 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 9080 |
| concepts[0].id | https://openalex.org/C8891405 |
| concepts[0].level | 2 |
| concepts[0].score | 0.6925424933433533 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[0].display_name | Immune system |
| concepts[1].id | https://openalex.org/C2778227246 |
| concepts[1].level | 2 |
| concepts[1].score | 0.638283908367157 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1365309 |
| concepts[1].display_name | Glioma |
| concepts[2].id | https://openalex.org/C2776107976 |
| concepts[2].level | 3 |
| concepts[2].score | 0.6236457228660583 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1786433 |
| concepts[2].display_name | Tumor microenvironment |
| concepts[3].id | https://openalex.org/C502942594 |
| concepts[3].level | 1 |
| concepts[3].score | 0.5621281266212463 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[3].display_name | Cancer research |
| concepts[4].id | https://openalex.org/C2779830541 |
| concepts[4].level | 3 |
| concepts[4].score | 0.5586950182914734 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1622829 |
| concepts[4].display_name | Microglia |
| concepts[5].id | https://openalex.org/C13373296 |
| concepts[5].level | 3 |
| concepts[5].score | 0.5531013011932373 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q421866 |
| concepts[5].display_name | Chemokine |
| concepts[6].id | https://openalex.org/C2780851360 |
| concepts[6].level | 4 |
| concepts[6].score | 0.5385746359825134 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q21686041 |
| concepts[6].display_name | Immune checkpoint |
| concepts[7].id | https://openalex.org/C164027704 |
| concepts[7].level | 3 |
| concepts[7].score | 0.4833390414714813 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q3491837 |
| concepts[7].display_name | Proinflammatory cytokine |
| concepts[8].id | https://openalex.org/C86803240 |
| concepts[8].level | 0 |
| concepts[8].score | 0.4585994482040405 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[8].display_name | Biology |
| concepts[9].id | https://openalex.org/C2778468042 |
| concepts[9].level | 3 |
| concepts[9].score | 0.4554223418235779 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q273976 |
| concepts[9].display_name | Blockade |
| concepts[10].id | https://openalex.org/C2777701055 |
| concepts[10].level | 3 |
| concepts[10].score | 0.4262847304344177 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q1427096 |
| concepts[10].display_name | Immunotherapy |
| concepts[11].id | https://openalex.org/C203014093 |
| concepts[11].level | 1 |
| concepts[11].score | 0.39878320693969727 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[11].display_name | Immunology |
| concepts[12].id | https://openalex.org/C71924100 |
| concepts[12].level | 0 |
| concepts[12].score | 0.3401505649089813 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[12].display_name | Medicine |
| concepts[13].id | https://openalex.org/C2776914184 |
| concepts[13].level | 2 |
| concepts[13].score | 0.1759667694568634 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q101991 |
| concepts[13].display_name | Inflammation |
| concepts[14].id | https://openalex.org/C170493617 |
| concepts[14].level | 2 |
| concepts[14].score | 0.07694181799888611 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[14].display_name | Receptor |
| concepts[15].id | https://openalex.org/C55493867 |
| concepts[15].level | 1 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[15].display_name | Biochemistry |
| keywords[0].id | https://openalex.org/keywords/immune-system |
| keywords[0].score | 0.6925424933433533 |
| keywords[0].display_name | Immune system |
| keywords[1].id | https://openalex.org/keywords/glioma |
| keywords[1].score | 0.638283908367157 |
| keywords[1].display_name | Glioma |
| keywords[2].id | https://openalex.org/keywords/tumor-microenvironment |
| keywords[2].score | 0.6236457228660583 |
| keywords[2].display_name | Tumor microenvironment |
| keywords[3].id | https://openalex.org/keywords/cancer-research |
| keywords[3].score | 0.5621281266212463 |
| keywords[3].display_name | Cancer research |
| keywords[4].id | https://openalex.org/keywords/microglia |
| keywords[4].score | 0.5586950182914734 |
| keywords[4].display_name | Microglia |
| keywords[5].id | https://openalex.org/keywords/chemokine |
| keywords[5].score | 0.5531013011932373 |
| keywords[5].display_name | Chemokine |
| keywords[6].id | https://openalex.org/keywords/immune-checkpoint |
| keywords[6].score | 0.5385746359825134 |
| keywords[6].display_name | Immune checkpoint |
| keywords[7].id | https://openalex.org/keywords/proinflammatory-cytokine |
| keywords[7].score | 0.4833390414714813 |
| keywords[7].display_name | Proinflammatory cytokine |
| keywords[8].id | https://openalex.org/keywords/biology |
| keywords[8].score | 0.4585994482040405 |
| keywords[8].display_name | Biology |
| keywords[9].id | https://openalex.org/keywords/blockade |
| keywords[9].score | 0.4554223418235779 |
| keywords[9].display_name | Blockade |
| keywords[10].id | https://openalex.org/keywords/immunotherapy |
| keywords[10].score | 0.4262847304344177 |
| keywords[10].display_name | Immunotherapy |
| keywords[11].id | https://openalex.org/keywords/immunology |
| keywords[11].score | 0.39878320693969727 |
| keywords[11].display_name | Immunology |
| keywords[12].id | https://openalex.org/keywords/medicine |
| keywords[12].score | 0.3401505649089813 |
| keywords[12].display_name | Medicine |
| keywords[13].id | https://openalex.org/keywords/inflammation |
| keywords[13].score | 0.1759667694568634 |
| keywords[13].display_name | Inflammation |
| keywords[14].id | https://openalex.org/keywords/receptor |
| keywords[14].score | 0.07694181799888611 |
| keywords[14].display_name | Receptor |
| language | en |
| locations[0].id | doi:10.1016/j.ccell.2023.09.001 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S25671836 |
| locations[0].source.issn | 1535-6108, 1878-3686 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1535-6108 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Cancer Cell |
| locations[0].source.host_organization | https://openalex.org/P4310315673 |
| locations[0].source.host_organization_name | Cell Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310315673, https://openalex.org/P4310320990 |
| locations[0].source.host_organization_lineage_names | Cell Press, Elsevier BV |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | https://ars.els-cdn.com/content/image/1-s2.0-S1535610823003185-fx1_lrg.jpg |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Cancer Cell |
| locations[0].landing_page_url | https://doi.org/10.1016/j.ccell.2023.09.001 |
| locations[1].id | pmid:37802053 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Cancer cell |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/37802053 |
| locations[2].id | pmh:oai:www.zora.uzh.ch:252467 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401281 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Zurich Open Repository and Archive (University of Zurich) |
| locations[2].source.host_organization | https://openalex.org/I202697423 |
| locations[2].source.host_organization_name | University of Zurich |
| locations[2].source.host_organization_lineage | https://openalex.org/I202697423 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | publishedVersion |
| locations[2].raw_type | info:eu-repo/semantics/publishedVersion |
| locations[2].license_id | |
| locations[2].is_accepted | True |
| locations[2].is_published | True |
| locations[2].raw_source_name | Ausejo-Mauleon, Iker; Labiano, Sara; de la Nava, Daniel; Laspidea, Virginia; Zalacain, Marta; Marrodán, Lucía; García-Moure, Marc; González-Huarriz, Marisol; Hervás-Corpión, Irati; Dhandapani, Laasya; Vicent, Silvestre; Collantes, Maria; Peñuelas, Iván; Becher, Oren J; Filbin, Mariella G; Jiang, Li; Labelle, Jenna; de Biagi-Junior, Carlos A O; Nazarian, Javad; Laternser, Sandra; Phoenix, Timothy N; van der Lugt, Jasper; Kranendonk, Mariette; Hoogendijk, Raoull; Mueller, Sabine; De Andrea, Carlos; Anderson, Ana C; Guruceaga, Elizabeth; Koschmann, Carl; Yadav, Viveka Nand; et al (2023). TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory. Cancer Cell, 41(11):1911-1926.e8. |
| locations[2].landing_page_url | |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:10644900 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | cc-by-nc |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Cancer Cell |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10644900 |
| locations[4].id | doi:10.5167/uzh-252467 |
| locations[4].is_oa | True |
| locations[4].source.id | https://openalex.org/S7407051291 |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | Universität Zürich, ZORA |
| locations[4].source.host_organization | |
| locations[4].source.host_organization_name | |
| locations[4].license | |
| locations[4].pdf_url | |
| locations[4].version | |
| locations[4].raw_type | article-journal |
| locations[4].license_id | |
| locations[4].is_accepted | False |
| locations[4].is_published | |
| locations[4].raw_source_name | |
| locations[4].landing_page_url | https://doi.org/10.5167/uzh-252467 |
| indexed_in | crossref, datacite, pubmed |
| authorships[0].author.id | https://openalex.org/A5023916916 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-0590-6579 |
| authorships[0].author.display_name | Iker Ausejo‐Mauleon |
| authorships[0].countries | ES |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210135003 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I88155538 |
| authorships[0].affiliations[1].raw_affiliation_string | Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[0].affiliations[2].institution_ids | https://openalex.org/I4210112085 |
| authorships[0].affiliations[2].raw_affiliation_string | Health Research Institute of Navarra (IdiSNA), Pamplona, Spain |
| authorships[0].institutions[0].id | https://openalex.org/I4210135003 |
| authorships[0].institutions[0].ror | https://ror.org/03phm3r45 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210135003 |
| authorships[0].institutions[0].country_code | ES |
| authorships[0].institutions[0].display_name | Clinica Universidad de Navarra |
| authorships[0].institutions[1].id | https://openalex.org/I4210112085 |
| authorships[0].institutions[1].ror | https://ror.org/023d5h353 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I4210112085 |
| authorships[0].institutions[1].country_code | ES |
| authorships[0].institutions[1].display_name | Navarre Institute of Health Research |
| authorships[0].institutions[2].id | https://openalex.org/I88155538 |
| authorships[0].institutions[2].ror | https://ror.org/02rxc7m23 |
| authorships[0].institutions[2].type | education |
| authorships[0].institutions[2].lineage | https://openalex.org/I88155538 |
| authorships[0].institutions[2].country_code | ES |
| authorships[0].institutions[2].display_name | Universidad de Navarra |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Iker Ausejo-Mauleon |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain, Health Research Institute of Navarra (IdiSNA), Pamplona, Spain, Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[1].author.id | https://openalex.org/A5077791294 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-2173-9416 |
| authorships[1].author.display_name | Sara Labiano |
| authorships[1].countries | ES |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I88155538 |
| authorships[1].affiliations[0].raw_affiliation_string | Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I4210112085 |
| authorships[1].affiliations[1].raw_affiliation_string | Health Research Institute of Navarra (IdiSNA), Pamplona, Spain |
| authorships[1].affiliations[2].institution_ids | https://openalex.org/I4210135003 |
| authorships[1].affiliations[2].raw_affiliation_string | Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain |
| authorships[1].institutions[0].id | https://openalex.org/I4210135003 |
| authorships[1].institutions[0].ror | https://ror.org/03phm3r45 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210135003 |
| authorships[1].institutions[0].country_code | ES |
| authorships[1].institutions[0].display_name | Clinica Universidad de Navarra |
| authorships[1].institutions[1].id | https://openalex.org/I4210112085 |
| authorships[1].institutions[1].ror | https://ror.org/023d5h353 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I4210112085 |
| authorships[1].institutions[1].country_code | ES |
| authorships[1].institutions[1].display_name | Navarre Institute of Health Research |
| authorships[1].institutions[2].id | https://openalex.org/I88155538 |
| authorships[1].institutions[2].ror | https://ror.org/02rxc7m23 |
| authorships[1].institutions[2].type | education |
| authorships[1].institutions[2].lineage | https://openalex.org/I88155538 |
| authorships[1].institutions[2].country_code | ES |
| authorships[1].institutions[2].display_name | Universidad de Navarra |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Sara Labiano |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain, Health Research Institute of Navarra (IdiSNA), Pamplona, Spain, Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[2].author.id | https://openalex.org/A5069729725 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-0626-0711 |
| authorships[2].author.display_name | Daniel de la Nava |
| authorships[2].countries | ES |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I88155538 |
| authorships[2].affiliations[0].raw_affiliation_string | Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I4210135003 |
| authorships[2].affiliations[1].raw_affiliation_string | Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain |
| authorships[2].affiliations[2].institution_ids | https://openalex.org/I4210112085 |
| authorships[2].affiliations[2].raw_affiliation_string | Health Research Institute of Navarra (IdiSNA), Pamplona, Spain |
| authorships[2].institutions[0].id | https://openalex.org/I4210135003 |
| authorships[2].institutions[0].ror | https://ror.org/03phm3r45 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210135003 |
| authorships[2].institutions[0].country_code | ES |
| authorships[2].institutions[0].display_name | Clinica Universidad de Navarra |
| authorships[2].institutions[1].id | https://openalex.org/I4210112085 |
| authorships[2].institutions[1].ror | https://ror.org/023d5h353 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I4210112085 |
| authorships[2].institutions[1].country_code | ES |
| authorships[2].institutions[1].display_name | Navarre Institute of Health Research |
| authorships[2].institutions[2].id | https://openalex.org/I88155538 |
| authorships[2].institutions[2].ror | https://ror.org/02rxc7m23 |
| authorships[2].institutions[2].type | education |
| authorships[2].institutions[2].lineage | https://openalex.org/I88155538 |
| authorships[2].institutions[2].country_code | ES |
| authorships[2].institutions[2].display_name | Universidad de Navarra |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Daniel de la Nava |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain, Health Research Institute of Navarra (IdiSNA), Pamplona, Spain, Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[3].author.id | https://openalex.org/A5043322499 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-6017-7295 |
| authorships[3].author.display_name | Virginia Laspidea |
| authorships[3].countries | ES |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210135003 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I88155538 |
| authorships[3].affiliations[1].raw_affiliation_string | Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[3].affiliations[2].institution_ids | https://openalex.org/I4210112085 |
| authorships[3].affiliations[2].raw_affiliation_string | Health Research Institute of Navarra (IdiSNA), Pamplona, Spain |
| authorships[3].institutions[0].id | https://openalex.org/I4210135003 |
| authorships[3].institutions[0].ror | https://ror.org/03phm3r45 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210135003 |
| authorships[3].institutions[0].country_code | ES |
| authorships[3].institutions[0].display_name | Clinica Universidad de Navarra |
| authorships[3].institutions[1].id | https://openalex.org/I4210112085 |
| authorships[3].institutions[1].ror | https://ror.org/023d5h353 |
| authorships[3].institutions[1].type | education |
| authorships[3].institutions[1].lineage | https://openalex.org/I4210112085 |
| authorships[3].institutions[1].country_code | ES |
| authorships[3].institutions[1].display_name | Navarre Institute of Health Research |
| authorships[3].institutions[2].id | https://openalex.org/I88155538 |
| authorships[3].institutions[2].ror | https://ror.org/02rxc7m23 |
| authorships[3].institutions[2].type | education |
| authorships[3].institutions[2].lineage | https://openalex.org/I88155538 |
| authorships[3].institutions[2].country_code | ES |
| authorships[3].institutions[2].display_name | Universidad de Navarra |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Virginia Laspidea |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain, Health Research Institute of Navarra (IdiSNA), Pamplona, Spain, Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[4].author.id | https://openalex.org/A5108141341 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Marta Zalacain |
| authorships[4].countries | ES |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210112085 |
| authorships[4].affiliations[0].raw_affiliation_string | Health Research Institute of Navarra (IdiSNA), Pamplona, Spain |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I88155538 |
| authorships[4].affiliations[1].raw_affiliation_string | Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[4].affiliations[2].institution_ids | https://openalex.org/I4210135003 |
| authorships[4].affiliations[2].raw_affiliation_string | Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain |
| authorships[4].institutions[0].id | https://openalex.org/I4210135003 |
| authorships[4].institutions[0].ror | https://ror.org/03phm3r45 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210135003 |
| authorships[4].institutions[0].country_code | ES |
| authorships[4].institutions[0].display_name | Clinica Universidad de Navarra |
| authorships[4].institutions[1].id | https://openalex.org/I4210112085 |
| authorships[4].institutions[1].ror | https://ror.org/023d5h353 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I4210112085 |
| authorships[4].institutions[1].country_code | ES |
| authorships[4].institutions[1].display_name | Navarre Institute of Health Research |
| authorships[4].institutions[2].id | https://openalex.org/I88155538 |
| authorships[4].institutions[2].ror | https://ror.org/02rxc7m23 |
| authorships[4].institutions[2].type | education |
| authorships[4].institutions[2].lineage | https://openalex.org/I88155538 |
| authorships[4].institutions[2].country_code | ES |
| authorships[4].institutions[2].display_name | Universidad de Navarra |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Marta Zalacain |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain, Health Research Institute of Navarra (IdiSNA), Pamplona, Spain, Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[5].author.id | https://openalex.org/A5035497290 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-1588-9052 |
| authorships[5].author.display_name | Lucía Marrodán |
| authorships[5].countries | ES |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I88155538 |
| authorships[5].affiliations[0].raw_affiliation_string | Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I4210112085 |
| authorships[5].affiliations[1].raw_affiliation_string | Health Research Institute of Navarra (IdiSNA), Pamplona, Spain |
| authorships[5].affiliations[2].institution_ids | https://openalex.org/I4210135003 |
| authorships[5].affiliations[2].raw_affiliation_string | Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain |
| authorships[5].institutions[0].id | https://openalex.org/I4210135003 |
| authorships[5].institutions[0].ror | https://ror.org/03phm3r45 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210135003 |
| authorships[5].institutions[0].country_code | ES |
| authorships[5].institutions[0].display_name | Clinica Universidad de Navarra |
| authorships[5].institutions[1].id | https://openalex.org/I4210112085 |
| authorships[5].institutions[1].ror | https://ror.org/023d5h353 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I4210112085 |
| authorships[5].institutions[1].country_code | ES |
| authorships[5].institutions[1].display_name | Navarre Institute of Health Research |
| authorships[5].institutions[2].id | https://openalex.org/I88155538 |
| authorships[5].institutions[2].ror | https://ror.org/02rxc7m23 |
| authorships[5].institutions[2].type | education |
| authorships[5].institutions[2].lineage | https://openalex.org/I88155538 |
| authorships[5].institutions[2].country_code | ES |
| authorships[5].institutions[2].display_name | Universidad de Navarra |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Lucía Marrodán |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain, Health Research Institute of Navarra (IdiSNA), Pamplona, Spain, Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[6].author.id | https://openalex.org/A5038432727 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-4365-7753 |
| authorships[6].author.display_name | Marc García-Moure |
| authorships[6].countries | ES |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210135003 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I4210112085 |
| authorships[6].affiliations[1].raw_affiliation_string | Health Research Institute of Navarra (IdiSNA), Pamplona, Spain |
| authorships[6].affiliations[2].institution_ids | https://openalex.org/I88155538 |
| authorships[6].affiliations[2].raw_affiliation_string | Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[6].institutions[0].id | https://openalex.org/I4210135003 |
| authorships[6].institutions[0].ror | https://ror.org/03phm3r45 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210135003 |
| authorships[6].institutions[0].country_code | ES |
| authorships[6].institutions[0].display_name | Clinica Universidad de Navarra |
| authorships[6].institutions[1].id | https://openalex.org/I4210112085 |
| authorships[6].institutions[1].ror | https://ror.org/023d5h353 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I4210112085 |
| authorships[6].institutions[1].country_code | ES |
| authorships[6].institutions[1].display_name | Navarre Institute of Health Research |
| authorships[6].institutions[2].id | https://openalex.org/I88155538 |
| authorships[6].institutions[2].ror | https://ror.org/02rxc7m23 |
| authorships[6].institutions[2].type | education |
| authorships[6].institutions[2].lineage | https://openalex.org/I88155538 |
| authorships[6].institutions[2].country_code | ES |
| authorships[6].institutions[2].display_name | Universidad de Navarra |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Marc García-Moure |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain, Health Research Institute of Navarra (IdiSNA), Pamplona, Spain, Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[7].author.id | https://openalex.org/A5057956194 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-0438-0077 |
| authorships[7].author.display_name | Marisol González-Huarriz |
| authorships[7].countries | ES |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I88155538 |
| authorships[7].affiliations[0].raw_affiliation_string | Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[7].affiliations[1].institution_ids | https://openalex.org/I4210135003 |
| authorships[7].affiliations[1].raw_affiliation_string | Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain |
| authorships[7].affiliations[2].institution_ids | https://openalex.org/I4210112085 |
| authorships[7].affiliations[2].raw_affiliation_string | Health Research Institute of Navarra (IdiSNA), Pamplona, Spain |
| authorships[7].institutions[0].id | https://openalex.org/I4210135003 |
| authorships[7].institutions[0].ror | https://ror.org/03phm3r45 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210135003 |
| authorships[7].institutions[0].country_code | ES |
| authorships[7].institutions[0].display_name | Clinica Universidad de Navarra |
| authorships[7].institutions[1].id | https://openalex.org/I4210112085 |
| authorships[7].institutions[1].ror | https://ror.org/023d5h353 |
| authorships[7].institutions[1].type | education |
| authorships[7].institutions[1].lineage | https://openalex.org/I4210112085 |
| authorships[7].institutions[1].country_code | ES |
| authorships[7].institutions[1].display_name | Navarre Institute of Health Research |
| authorships[7].institutions[2].id | https://openalex.org/I88155538 |
| authorships[7].institutions[2].ror | https://ror.org/02rxc7m23 |
| authorships[7].institutions[2].type | education |
| authorships[7].institutions[2].lineage | https://openalex.org/I88155538 |
| authorships[7].institutions[2].country_code | ES |
| authorships[7].institutions[2].display_name | Universidad de Navarra |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Marisol González-Huarriz |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain, Health Research Institute of Navarra (IdiSNA), Pamplona, Spain, Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[8].author.id | https://openalex.org/A5068186871 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-3991-4147 |
| authorships[8].author.display_name | Irati Hervás-Corpión |
| authorships[8].countries | ES |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210112085 |
| authorships[8].affiliations[0].raw_affiliation_string | Health Research Institute of Navarra (IdiSNA), Pamplona, Spain |
| authorships[8].affiliations[1].institution_ids | https://openalex.org/I4210135003 |
| authorships[8].affiliations[1].raw_affiliation_string | Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain |
| authorships[8].affiliations[2].institution_ids | https://openalex.org/I88155538 |
| authorships[8].affiliations[2].raw_affiliation_string | Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[8].institutions[0].id | https://openalex.org/I4210135003 |
| authorships[8].institutions[0].ror | https://ror.org/03phm3r45 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210135003 |
| authorships[8].institutions[0].country_code | ES |
| authorships[8].institutions[0].display_name | Clinica Universidad de Navarra |
| authorships[8].institutions[1].id | https://openalex.org/I4210112085 |
| authorships[8].institutions[1].ror | https://ror.org/023d5h353 |
| authorships[8].institutions[1].type | education |
| authorships[8].institutions[1].lineage | https://openalex.org/I4210112085 |
| authorships[8].institutions[1].country_code | ES |
| authorships[8].institutions[1].display_name | Navarre Institute of Health Research |
| authorships[8].institutions[2].id | https://openalex.org/I88155538 |
| authorships[8].institutions[2].ror | https://ror.org/02rxc7m23 |
| authorships[8].institutions[2].type | education |
| authorships[8].institutions[2].lineage | https://openalex.org/I88155538 |
| authorships[8].institutions[2].country_code | ES |
| authorships[8].institutions[2].display_name | Universidad de Navarra |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Irati Hervás-Corpión |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain, Health Research Institute of Navarra (IdiSNA), Pamplona, Spain, Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[9].author.id | https://openalex.org/A5053164965 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-4190-8408 |
| authorships[9].author.display_name | Laasya Dhandapani |
| authorships[9].countries | ES |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I88155538 |
| authorships[9].affiliations[0].raw_affiliation_string | Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[9].affiliations[1].institution_ids | https://openalex.org/I4210135003 |
| authorships[9].affiliations[1].raw_affiliation_string | Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain |
| authorships[9].affiliations[2].institution_ids | https://openalex.org/I4210112085 |
| authorships[9].affiliations[2].raw_affiliation_string | Health Research Institute of Navarra (IdiSNA), Pamplona, Spain |
| authorships[9].institutions[0].id | https://openalex.org/I4210135003 |
| authorships[9].institutions[0].ror | https://ror.org/03phm3r45 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210135003 |
| authorships[9].institutions[0].country_code | ES |
| authorships[9].institutions[0].display_name | Clinica Universidad de Navarra |
| authorships[9].institutions[1].id | https://openalex.org/I4210112085 |
| authorships[9].institutions[1].ror | https://ror.org/023d5h353 |
| authorships[9].institutions[1].type | education |
| authorships[9].institutions[1].lineage | https://openalex.org/I4210112085 |
| authorships[9].institutions[1].country_code | ES |
| authorships[9].institutions[1].display_name | Navarre Institute of Health Research |
| authorships[9].institutions[2].id | https://openalex.org/I88155538 |
| authorships[9].institutions[2].ror | https://ror.org/02rxc7m23 |
| authorships[9].institutions[2].type | education |
| authorships[9].institutions[2].lineage | https://openalex.org/I88155538 |
| authorships[9].institutions[2].country_code | ES |
| authorships[9].institutions[2].display_name | Universidad de Navarra |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Laasya Dhandapani |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain, Health Research Institute of Navarra (IdiSNA), Pamplona, Spain, Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[10].author.id | https://openalex.org/A5003533040 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Silvestre Vicent |
| authorships[10].countries | ES |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210112085 |
| authorships[10].affiliations[0].raw_affiliation_string | Health Research Institute of Navarra (IdiSNA), Pamplona, Spain |
| authorships[10].affiliations[1].institution_ids | https://openalex.org/I88155538 |
| authorships[10].affiliations[1].raw_affiliation_string | Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[10].institutions[0].id | https://openalex.org/I4210112085 |
| authorships[10].institutions[0].ror | https://ror.org/023d5h353 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210112085 |
| authorships[10].institutions[0].country_code | ES |
| authorships[10].institutions[0].display_name | Navarre Institute of Health Research |
| authorships[10].institutions[1].id | https://openalex.org/I88155538 |
| authorships[10].institutions[1].ror | https://ror.org/02rxc7m23 |
| authorships[10].institutions[1].type | education |
| authorships[10].institutions[1].lineage | https://openalex.org/I88155538 |
| authorships[10].institutions[1].country_code | ES |
| authorships[10].institutions[1].display_name | Universidad de Navarra |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Silvestre Vicent |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Health Research Institute of Navarra (IdiSNA), Pamplona, Spain, Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[11].author.id | https://openalex.org/A5007339532 |
| authorships[11].author.orcid | https://orcid.org/0000-0003-1162-1470 |
| authorships[11].author.display_name | María Collantes |
| authorships[11].countries | ES |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210135003 |
| authorships[11].affiliations[0].raw_affiliation_string | Radiopharmacy Unit, Clínica Universidad de Navarra, Pamplona, Spain |
| authorships[11].affiliations[1].institution_ids | https://openalex.org/I4210135003 |
| authorships[11].affiliations[1].raw_affiliation_string | Translational Molecular Imaging Unit, Clínica Universidad de Navarra, Pamplona, Spain |
| authorships[11].institutions[0].id | https://openalex.org/I4210135003 |
| authorships[11].institutions[0].ror | https://ror.org/03phm3r45 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210135003 |
| authorships[11].institutions[0].country_code | ES |
| authorships[11].institutions[0].display_name | Clinica Universidad de Navarra |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Maria Collantes |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Radiopharmacy Unit, Clínica Universidad de Navarra, Pamplona, Spain, Translational Molecular Imaging Unit, Clínica Universidad de Navarra, Pamplona, Spain |
| authorships[12].author.id | https://openalex.org/A5013934560 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-8008-976X |
| authorships[12].author.display_name | Iván Peñuelas |
| authorships[12].countries | ES |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210135003 |
| authorships[12].affiliations[0].raw_affiliation_string | Radiopharmacy Unit, Clínica Universidad de Navarra, Pamplona, Spain |
| authorships[12].affiliations[1].institution_ids | https://openalex.org/I4210135003 |
| authorships[12].affiliations[1].raw_affiliation_string | Translational Molecular Imaging Unit, Clínica Universidad de Navarra, Pamplona, Spain |
| authorships[12].affiliations[2].institution_ids | https://openalex.org/I4210112085 |
| authorships[12].affiliations[2].raw_affiliation_string | Health Research Institute of Navarra (IdiSNA), Pamplona, Spain |
| authorships[12].institutions[0].id | https://openalex.org/I4210135003 |
| authorships[12].institutions[0].ror | https://ror.org/03phm3r45 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210135003 |
| authorships[12].institutions[0].country_code | ES |
| authorships[12].institutions[0].display_name | Clinica Universidad de Navarra |
| authorships[12].institutions[1].id | https://openalex.org/I4210112085 |
| authorships[12].institutions[1].ror | https://ror.org/023d5h353 |
| authorships[12].institutions[1].type | education |
| authorships[12].institutions[1].lineage | https://openalex.org/I4210112085 |
| authorships[12].institutions[1].country_code | ES |
| authorships[12].institutions[1].display_name | Navarre Institute of Health Research |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Iván Peñuelas |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Health Research Institute of Navarra (IdiSNA), Pamplona, Spain, Radiopharmacy Unit, Clínica Universidad de Navarra, Pamplona, Spain, Translational Molecular Imaging Unit, Clínica Universidad de Navarra, Pamplona, Spain |
| authorships[13].author.id | https://openalex.org/A5089189433 |
| authorships[13].author.orcid | https://orcid.org/0000-0003-4016-8492 |
| authorships[13].author.display_name | Oren J. Becher |
| authorships[13].affiliations[0].raw_affiliation_string | Jack Martin Fund Division of Pediatric Hematology-oncology, Mount Sinai, New York, NY, USA |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Oren J. Becher |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Jack Martin Fund Division of Pediatric Hematology-oncology, Mount Sinai, New York, NY, USA |
| authorships[14].author.id | https://openalex.org/A5002271939 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-2613-8126 |
| authorships[14].author.display_name | Mariella G. Filbin |
| authorships[14].countries | US |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I107606265 |
| authorships[14].affiliations[0].raw_affiliation_string | Broad Institute of Harvard and MIT, Cambridge, MA, USA |
| authorships[14].affiliations[1].institution_ids | https://openalex.org/I4210166317 |
| authorships[14].affiliations[1].raw_affiliation_string | Department of Pediatric Oncology, Dana-Farber Boston Children’s Cancer and Blood Disorders Center, Boston, MA, USA |
| authorships[14].institutions[0].id | https://openalex.org/I107606265 |
| authorships[14].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[14].institutions[0].type | nonprofit |
| authorships[14].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[14].institutions[0].country_code | US |
| authorships[14].institutions[0].display_name | Broad Institute |
| authorships[14].institutions[1].id | https://openalex.org/I4210166317 |
| authorships[14].institutions[1].ror | https://ror.org/05k11pb55 |
| authorships[14].institutions[1].type | healthcare |
| authorships[14].institutions[1].lineage | https://openalex.org/I1288882113, https://openalex.org/I4210117453, https://openalex.org/I4210166317 |
| authorships[14].institutions[1].country_code | US |
| authorships[14].institutions[1].display_name | Dana-Farber/Boston Children's Cancer and Blood Disorders Center |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Mariella G. Filbin |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Broad Institute of Harvard and MIT, Cambridge, MA, USA, Department of Pediatric Oncology, Dana-Farber Boston Children’s Cancer and Blood Disorders Center, Boston, MA, USA |
| authorships[15].author.id | https://openalex.org/A5089653376 |
| authorships[15].author.orcid | https://orcid.org/0000-0001-7320-5283 |
| authorships[15].author.display_name | Li Jiang |
| authorships[15].countries | US |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I4210166317 |
| authorships[15].affiliations[0].raw_affiliation_string | Department of Pediatric Oncology, Dana-Farber Boston Children’s Cancer and Blood Disorders Center, Boston, MA, USA |
| authorships[15].affiliations[1].institution_ids | https://openalex.org/I107606265 |
| authorships[15].affiliations[1].raw_affiliation_string | Broad Institute of Harvard and MIT, Cambridge, MA, USA |
| authorships[15].institutions[0].id | https://openalex.org/I107606265 |
| authorships[15].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[15].institutions[0].type | nonprofit |
| authorships[15].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[15].institutions[0].country_code | US |
| authorships[15].institutions[0].display_name | Broad Institute |
| authorships[15].institutions[1].id | https://openalex.org/I4210166317 |
| authorships[15].institutions[1].ror | https://ror.org/05k11pb55 |
| authorships[15].institutions[1].type | healthcare |
| authorships[15].institutions[1].lineage | https://openalex.org/I1288882113, https://openalex.org/I4210117453, https://openalex.org/I4210166317 |
| authorships[15].institutions[1].country_code | US |
| authorships[15].institutions[1].display_name | Dana-Farber/Boston Children's Cancer and Blood Disorders Center |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Li Jiang |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Broad Institute of Harvard and MIT, Cambridge, MA, USA, Department of Pediatric Oncology, Dana-Farber Boston Children’s Cancer and Blood Disorders Center, Boston, MA, USA |
| authorships[16].author.id | https://openalex.org/A5046207435 |
| authorships[16].author.orcid | https://orcid.org/0000-0003-3843-320X |
| authorships[16].author.display_name | Jenna LaBelle |
| authorships[16].countries | US |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I4210166317 |
| authorships[16].affiliations[0].raw_affiliation_string | Department of Pediatric Oncology, Dana-Farber Boston Children’s Cancer and Blood Disorders Center, Boston, MA, USA |
| authorships[16].affiliations[1].institution_ids | https://openalex.org/I107606265 |
| authorships[16].affiliations[1].raw_affiliation_string | Broad Institute of Harvard and MIT, Cambridge, MA, USA |
| authorships[16].institutions[0].id | https://openalex.org/I107606265 |
| authorships[16].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[16].institutions[0].type | nonprofit |
| authorships[16].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[16].institutions[0].country_code | US |
| authorships[16].institutions[0].display_name | Broad Institute |
| authorships[16].institutions[1].id | https://openalex.org/I4210166317 |
| authorships[16].institutions[1].ror | https://ror.org/05k11pb55 |
| authorships[16].institutions[1].type | healthcare |
| authorships[16].institutions[1].lineage | https://openalex.org/I1288882113, https://openalex.org/I4210117453, https://openalex.org/I4210166317 |
| authorships[16].institutions[1].country_code | US |
| authorships[16].institutions[1].display_name | Dana-Farber/Boston Children's Cancer and Blood Disorders Center |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Jenna Labelle |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Broad Institute of Harvard and MIT, Cambridge, MA, USA, Department of Pediatric Oncology, Dana-Farber Boston Children’s Cancer and Blood Disorders Center, Boston, MA, USA |
| authorships[17].author.id | https://openalex.org/A5110946193 |
| authorships[17].author.orcid | |
| authorships[17].author.display_name | Carlos A O de Biagi-Junior |
| authorships[17].countries | US |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I107606265 |
| authorships[17].affiliations[0].raw_affiliation_string | Broad Institute of Harvard and MIT, Cambridge, MA, USA |
| authorships[17].affiliations[1].institution_ids | https://openalex.org/I4210166317 |
| authorships[17].affiliations[1].raw_affiliation_string | Department of Pediatric Oncology, Dana-Farber Boston Children’s Cancer and Blood Disorders Center, Boston, MA, USA |
| authorships[17].institutions[0].id | https://openalex.org/I107606265 |
| authorships[17].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[17].institutions[0].type | nonprofit |
| authorships[17].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[17].institutions[0].country_code | US |
| authorships[17].institutions[0].display_name | Broad Institute |
| authorships[17].institutions[1].id | https://openalex.org/I4210166317 |
| authorships[17].institutions[1].ror | https://ror.org/05k11pb55 |
| authorships[17].institutions[1].type | healthcare |
| authorships[17].institutions[1].lineage | https://openalex.org/I1288882113, https://openalex.org/I4210117453, https://openalex.org/I4210166317 |
| authorships[17].institutions[1].country_code | US |
| authorships[17].institutions[1].display_name | Dana-Farber/Boston Children's Cancer and Blood Disorders Center |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Carlos A.O. de Biagi-Junior |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Broad Institute of Harvard and MIT, Cambridge, MA, USA, Department of Pediatric Oncology, Dana-Farber Boston Children’s Cancer and Blood Disorders Center, Boston, MA, USA |
| authorships[18].author.id | https://openalex.org/A5005984345 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-1951-9828 |
| authorships[18].author.display_name | Javad Nazarian |
| authorships[18].countries | CH, US |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I4210128593 |
| authorships[18].affiliations[0].raw_affiliation_string | Division of Oncology and Children’s Research Center, DIPG/DMG Research Center Zurich, University Children’s Hospital Zurich, Zurich, Switzerland |
| authorships[18].affiliations[1].institution_ids | https://openalex.org/I1336742384 |
| authorships[18].affiliations[1].raw_affiliation_string | Children’s National Health System, Center for Genetic Medicine Research, Washington, DC, USA |
| authorships[18].affiliations[2].institution_ids | https://openalex.org/I859038795 |
| authorships[18].affiliations[2].raw_affiliation_string | Virginia Tech University, Washington, DC, USA |
| authorships[18].institutions[0].id | https://openalex.org/I4210128593 |
| authorships[18].institutions[0].ror | https://ror.org/035vb3h42 |
| authorships[18].institutions[0].type | healthcare |
| authorships[18].institutions[0].lineage | https://openalex.org/I4210128593 |
| authorships[18].institutions[0].country_code | CH |
| authorships[18].institutions[0].display_name | University Children's Hospital Zurich |
| authorships[18].institutions[1].id | https://openalex.org/I1336742384 |
| authorships[18].institutions[1].ror | https://ror.org/03wa2q724 |
| authorships[18].institutions[1].type | healthcare |
| authorships[18].institutions[1].lineage | https://openalex.org/I1336742384 |
| authorships[18].institutions[1].country_code | US |
| authorships[18].institutions[1].display_name | Children's National |
| authorships[18].institutions[2].id | https://openalex.org/I859038795 |
| authorships[18].institutions[2].ror | https://ror.org/02smfhw86 |
| authorships[18].institutions[2].type | education |
| authorships[18].institutions[2].lineage | https://openalex.org/I859038795 |
| authorships[18].institutions[2].country_code | US |
| authorships[18].institutions[2].display_name | Virginia Tech |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Javad Nazarian |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Children’s National Health System, Center for Genetic Medicine Research, Washington, DC, USA, Division of Oncology and Children’s Research Center, DIPG/DMG Research Center Zurich, University Children’s Hospital Zurich, Zurich, Switzerland, Virginia Tech University, Washington, DC, USA |
| authorships[19].author.id | https://openalex.org/A5012198115 |
| authorships[19].author.orcid | |
| authorships[19].author.display_name | Sandra Laternser |
| authorships[19].countries | CH |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I4210128593 |
| authorships[19].affiliations[0].raw_affiliation_string | Division of Oncology and Children’s Research Center, DIPG/DMG Research Center Zurich, University Children’s Hospital Zurich, Zurich, Switzerland |
| authorships[19].institutions[0].id | https://openalex.org/I4210128593 |
| authorships[19].institutions[0].ror | https://ror.org/035vb3h42 |
| authorships[19].institutions[0].type | healthcare |
| authorships[19].institutions[0].lineage | https://openalex.org/I4210128593 |
| authorships[19].institutions[0].country_code | CH |
| authorships[19].institutions[0].display_name | University Children's Hospital Zurich |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Sandra Laternser |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Division of Oncology and Children’s Research Center, DIPG/DMG Research Center Zurich, University Children’s Hospital Zurich, Zurich, Switzerland |
| authorships[20].author.id | https://openalex.org/A5066165052 |
| authorships[20].author.orcid | https://orcid.org/0000-0003-4771-4003 |
| authorships[20].author.display_name | Timothy N. Phoenix |
| authorships[20].countries | US |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I92156820 |
| authorships[20].affiliations[0].raw_affiliation_string | Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH, USA |
| authorships[20].institutions[0].id | https://openalex.org/I92156820 |
| authorships[20].institutions[0].ror | https://ror.org/02p72h367 |
| authorships[20].institutions[0].type | healthcare |
| authorships[20].institutions[0].lineage | https://openalex.org/I92156820 |
| authorships[20].institutions[0].country_code | US |
| authorships[20].institutions[0].display_name | University of Cincinnati Medical Center |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Timothy N. Phoenix |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH, USA |
| authorships[21].author.id | https://openalex.org/A5078018486 |
| authorships[21].author.orcid | https://orcid.org/0000-0002-8186-338X |
| authorships[21].author.display_name | Jasper van der Lugt |
| authorships[21].countries | NL |
| authorships[21].affiliations[0].institution_ids | https://openalex.org/I4210127118 |
| authorships[21].affiliations[0].raw_affiliation_string | Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands |
| authorships[21].institutions[0].id | https://openalex.org/I4210127118 |
| authorships[21].institutions[0].ror | https://ror.org/02aj7yc53 |
| authorships[21].institutions[0].type | healthcare |
| authorships[21].institutions[0].lineage | https://openalex.org/I4210127118 |
| authorships[21].institutions[0].country_code | NL |
| authorships[21].institutions[0].display_name | Princess Máxima Center |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Jasper van der Lugt |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands |
| authorships[22].author.id | https://openalex.org/A5038974602 |
| authorships[22].author.orcid | https://orcid.org/0000-0001-9683-7494 |
| authorships[22].author.display_name | Mariëtte E.G. Kranendonk |
| authorships[22].countries | CH |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I202697423 |
| authorships[22].affiliations[0].raw_affiliation_string | Zurich Open Repository and Archive University of Zurich University Library Strickhofstrasse 39 CH-8057 Zurich |
| authorships[22].institutions[0].id | https://openalex.org/I202697423 |
| authorships[22].institutions[0].ror | https://ror.org/02crff812 |
| authorships[22].institutions[0].type | education |
| authorships[22].institutions[0].lineage | https://openalex.org/I202697423 |
| authorships[22].institutions[0].country_code | CH |
| authorships[22].institutions[0].display_name | University of Zurich |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Mariette Kranendonk |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | Zurich Open Repository and Archive University of Zurich University Library Strickhofstrasse 39 CH-8057 Zurich |
| authorships[23].author.id | https://openalex.org/A5003483483 |
| authorships[23].author.orcid | https://orcid.org/0000-0002-8033-2093 |
| authorships[23].author.display_name | Raoull Hoogendijk |
| authorships[23].countries | CH |
| authorships[23].affiliations[0].institution_ids | https://openalex.org/I202697423 |
| authorships[23].affiliations[0].raw_affiliation_string | Zurich Open Repository and Archive University of Zurich University Library Strickhofstrasse 39 CH-8057 Zurich |
| authorships[23].institutions[0].id | https://openalex.org/I202697423 |
| authorships[23].institutions[0].ror | https://ror.org/02crff812 |
| authorships[23].institutions[0].type | education |
| authorships[23].institutions[0].lineage | https://openalex.org/I202697423 |
| authorships[23].institutions[0].country_code | CH |
| authorships[23].institutions[0].display_name | University of Zurich |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | Raoull Hoogendijk |
| authorships[23].is_corresponding | False |
| authorships[23].raw_affiliation_strings | Zurich Open Repository and Archive University of Zurich University Library Strickhofstrasse 39 CH-8057 Zurich |
| authorships[24].author.id | https://openalex.org/A5084156179 |
| authorships[24].author.orcid | https://orcid.org/0000-0002-3452-5150 |
| authorships[24].author.display_name | Sabine Mueller |
| authorships[24].countries | US |
| authorships[24].affiliations[0].institution_ids | https://openalex.org/I180670191 |
| authorships[24].affiliations[0].raw_affiliation_string | University of California, San Francisco, San Francisco, CA, USA |
| authorships[24].institutions[0].id | https://openalex.org/I180670191 |
| authorships[24].institutions[0].ror | https://ror.org/043mz5j54 |
| authorships[24].institutions[0].type | education |
| authorships[24].institutions[0].lineage | https://openalex.org/I180670191 |
| authorships[24].institutions[0].country_code | US |
| authorships[24].institutions[0].display_name | University of California, San Francisco |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | Sabine Mueller |
| authorships[24].is_corresponding | False |
| authorships[24].raw_affiliation_strings | University of California, San Francisco, San Francisco, CA, USA |
| authorships[25].author.id | https://openalex.org/A5109619462 |
| authorships[25].author.orcid | |
| authorships[25].author.display_name | Carlos de Andrea |
| authorships[25].countries | US |
| authorships[25].affiliations[0].institution_ids | https://openalex.org/I4210166317 |
| authorships[25].affiliations[0].raw_affiliation_string | Department of Pediatric Oncology, Dana-Farber Boston Children’s Cancer and Blood Disorders Center, Boston, MA, USA |
| authorships[25].affiliations[1].institution_ids | https://openalex.org/I107606265 |
| authorships[25].affiliations[1].raw_affiliation_string | Broad Institute of Harvard and MIT, Cambridge, MA, USA |
| authorships[25].institutions[0].id | https://openalex.org/I107606265 |
| authorships[25].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[25].institutions[0].type | nonprofit |
| authorships[25].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[25].institutions[0].country_code | US |
| authorships[25].institutions[0].display_name | Broad Institute |
| authorships[25].institutions[1].id | https://openalex.org/I4210166317 |
| authorships[25].institutions[1].ror | https://ror.org/05k11pb55 |
| authorships[25].institutions[1].type | healthcare |
| authorships[25].institutions[1].lineage | https://openalex.org/I1288882113, https://openalex.org/I4210117453, https://openalex.org/I4210166317 |
| authorships[25].institutions[1].country_code | US |
| authorships[25].institutions[1].display_name | Dana-Farber/Boston Children's Cancer and Blood Disorders Center |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | Carlos De Andrea |
| authorships[25].is_corresponding | False |
| authorships[25].raw_affiliation_strings | Broad Institute of Harvard and MIT, Cambridge, MA, USA, Department of Pediatric Oncology, Dana-Farber Boston Children’s Cancer and Blood Disorders Center, Boston, MA, USA |
| authorships[26].author.id | https://openalex.org/A5088775441 |
| authorships[26].author.orcid | https://orcid.org/0000-0002-0877-2932 |
| authorships[26].author.display_name | Ana C. Anderson |
| authorships[26].countries | US |
| authorships[26].affiliations[0].institution_ids | https://openalex.org/I1283280774, https://openalex.org/I136199984 |
| authorships[26].affiliations[0].raw_affiliation_string | Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA |
| authorships[26].affiliations[1].institution_ids | https://openalex.org/I1283280774, https://openalex.org/I136199984 |
| authorships[26].affiliations[1].raw_affiliation_string | Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA |
| authorships[26].institutions[0].id | https://openalex.org/I1283280774 |
| authorships[26].institutions[0].ror | https://ror.org/04b6nzv94 |
| authorships[26].institutions[0].type | healthcare |
| authorships[26].institutions[0].lineage | https://openalex.org/I1283280774, https://openalex.org/I48633490 |
| authorships[26].institutions[0].country_code | US |
| authorships[26].institutions[0].display_name | Brigham and Women's Hospital |
| authorships[26].institutions[1].id | https://openalex.org/I136199984 |
| authorships[26].institutions[1].ror | https://ror.org/03vek6s52 |
| authorships[26].institutions[1].type | education |
| authorships[26].institutions[1].lineage | https://openalex.org/I136199984 |
| authorships[26].institutions[1].country_code | US |
| authorships[26].institutions[1].display_name | Harvard University |
| authorships[26].author_position | middle |
| authorships[26].raw_author_name | Ana C. Anderson |
| authorships[26].is_corresponding | False |
| authorships[26].raw_affiliation_strings | Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA |
| authorships[27].author.id | https://openalex.org/A5043296656 |
| authorships[27].author.orcid | https://orcid.org/0000-0003-0547-681X |
| authorships[27].author.display_name | Elizabeth Guruceaga |
| authorships[27].countries | ES |
| authorships[27].affiliations[0].institution_ids | https://openalex.org/I88155538 |
| authorships[27].affiliations[0].raw_affiliation_string | Bioinformatics Platform, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[27].institutions[0].id | https://openalex.org/I88155538 |
| authorships[27].institutions[0].ror | https://ror.org/02rxc7m23 |
| authorships[27].institutions[0].type | education |
| authorships[27].institutions[0].lineage | https://openalex.org/I88155538 |
| authorships[27].institutions[0].country_code | ES |
| authorships[27].institutions[0].display_name | Universidad de Navarra |
| authorships[27].author_position | middle |
| authorships[27].raw_author_name | Elizabeth Guruceaga |
| authorships[27].is_corresponding | False |
| authorships[27].raw_affiliation_strings | Bioinformatics Platform, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[28].author.id | https://openalex.org/A5001293585 |
| authorships[28].author.orcid | https://orcid.org/0000-0002-0825-7615 |
| authorships[28].author.display_name | Carl Koschmann |
| authorships[28].countries | US |
| authorships[28].affiliations[0].institution_ids | https://openalex.org/I4210166317 |
| authorships[28].affiliations[0].raw_affiliation_string | Department of Pediatric Oncology, Dana-Farber Boston Children’s Cancer and Blood Disorders Center, Boston, MA, USA |
| authorships[28].affiliations[1].institution_ids | https://openalex.org/I107606265 |
| authorships[28].affiliations[1].raw_affiliation_string | Broad Institute of Harvard and MIT, Cambridge, MA, USA |
| authorships[28].institutions[0].id | https://openalex.org/I107606265 |
| authorships[28].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[28].institutions[0].type | nonprofit |
| authorships[28].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[28].institutions[0].country_code | US |
| authorships[28].institutions[0].display_name | Broad Institute |
| authorships[28].institutions[1].id | https://openalex.org/I4210166317 |
| authorships[28].institutions[1].ror | https://ror.org/05k11pb55 |
| authorships[28].institutions[1].type | healthcare |
| authorships[28].institutions[1].lineage | https://openalex.org/I1288882113, https://openalex.org/I4210117453, https://openalex.org/I4210166317 |
| authorships[28].institutions[1].country_code | US |
| authorships[28].institutions[1].display_name | Dana-Farber/Boston Children's Cancer and Blood Disorders Center |
| authorships[28].author_position | middle |
| authorships[28].raw_author_name | Carl Koschmann |
| authorships[28].is_corresponding | False |
| authorships[28].raw_affiliation_strings | Broad Institute of Harvard and MIT, Cambridge, MA, USA, Department of Pediatric Oncology, Dana-Farber Boston Children’s Cancer and Blood Disorders Center, Boston, MA, USA |
| authorships[29].author.id | https://openalex.org/A5081214038 |
| authorships[29].author.orcid | https://orcid.org/0009-0001-5354-3717 |
| authorships[29].author.display_name | Viveka Nand Yadav |
| authorships[29].countries | US |
| authorships[29].affiliations[0].institution_ids | https://openalex.org/I75421653 |
| authorships[29].affiliations[0].raw_affiliation_string | Department of Pediatrics, University of Missouri Kansas City School of Medicine, Kansas City, KS, USA |
| authorships[29].affiliations[1].institution_ids | https://openalex.org/I4210097601 |
| authorships[29].affiliations[1].raw_affiliation_string | Department of Cancer Biology, University of Kansas Cancer Center. Kansas City, KS, USA |
| authorships[29].affiliations[2].institution_ids | https://openalex.org/I4210148341 |
| authorships[29].affiliations[2].raw_affiliation_string | Department of Pediatrics, Children's Mercy Research Institute (CMRI), Kansas City, KS, USA |
| authorships[29].institutions[0].id | https://openalex.org/I4210148341 |
| authorships[29].institutions[0].ror | https://ror.org/03j99w497 |
| authorships[29].institutions[0].type | facility |
| authorships[29].institutions[0].lineage | https://openalex.org/I4210148341 |
| authorships[29].institutions[0].country_code | US |
| authorships[29].institutions[0].display_name | Mercy Research |
| authorships[29].institutions[1].id | https://openalex.org/I4210097601 |
| authorships[29].institutions[1].ror | https://ror.org/00cj35179 |
| authorships[29].institutions[1].type | facility |
| authorships[29].institutions[1].lineage | https://openalex.org/I4210097601 |
| authorships[29].institutions[1].country_code | US |
| authorships[29].institutions[1].display_name | The University of Kansas Cancer Center |
| authorships[29].institutions[2].id | https://openalex.org/I75421653 |
| authorships[29].institutions[2].ror | https://ror.org/01w0d5g70 |
| authorships[29].institutions[2].type | education |
| authorships[29].institutions[2].lineage | https://openalex.org/I75421653 |
| authorships[29].institutions[2].country_code | US |
| authorships[29].institutions[2].display_name | University of Missouri–Kansas City |
| authorships[29].author_position | middle |
| authorships[29].raw_author_name | Viveka Nand Yadav |
| authorships[29].is_corresponding | False |
| authorships[29].raw_affiliation_strings | Department of Cancer Biology, University of Kansas Cancer Center. Kansas City, KS, USA, Department of Pediatrics, Children's Mercy Research Institute (CMRI), Kansas City, KS, USA, Department of Pediatrics, University of Missouri Kansas City School of Medicine, Kansas City, KS, USA |
| authorships[30].author.id | https://openalex.org/A5005735935 |
| authorships[30].author.orcid | https://orcid.org/0000-0003-2969-0116 |
| authorships[30].author.display_name | Jaime Gállego Pérez‐Larraya |
| authorships[30].countries | ES |
| authorships[30].affiliations[0].institution_ids | https://openalex.org/I4210135003, https://openalex.org/I88155538 |
| authorships[30].affiliations[0].raw_affiliation_string | Department of Neurology, Clı ´nica Universidad de Navarra, Pamplona, Spain |
| authorships[30].institutions[0].id | https://openalex.org/I4210135003 |
| authorships[30].institutions[0].ror | https://ror.org/03phm3r45 |
| authorships[30].institutions[0].type | healthcare |
| authorships[30].institutions[0].lineage | https://openalex.org/I4210135003 |
| authorships[30].institutions[0].country_code | ES |
| authorships[30].institutions[0].display_name | Clinica Universidad de Navarra |
| authorships[30].institutions[1].id | https://openalex.org/I88155538 |
| authorships[30].institutions[1].ror | https://ror.org/02rxc7m23 |
| authorships[30].institutions[1].type | education |
| authorships[30].institutions[1].lineage | https://openalex.org/I88155538 |
| authorships[30].institutions[1].country_code | ES |
| authorships[30].institutions[1].display_name | Universidad de Navarra |
| authorships[30].author_position | middle |
| authorships[30].raw_author_name | Jaime Gállego Pérez-Larraya |
| authorships[30].is_corresponding | False |
| authorships[30].raw_affiliation_strings | Department of Neurology, Clı ´nica Universidad de Navarra, Pamplona, Spain |
| authorships[31].author.id | https://openalex.org/A5000183191 |
| authorships[31].author.orcid | https://orcid.org/0000-0002-4066-8203 |
| authorships[31].author.display_name | Ana Patiño-Garcı́a |
| authorships[31].countries | ES |
| authorships[31].affiliations[0].institution_ids | https://openalex.org/I4210135003 |
| authorships[31].affiliations[0].raw_affiliation_string | Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain |
| authorships[31].affiliations[1].institution_ids | https://openalex.org/I88155538 |
| authorships[31].affiliations[1].raw_affiliation_string | Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[31].affiliations[2].institution_ids | https://openalex.org/I4210112085 |
| authorships[31].affiliations[2].raw_affiliation_string | Health Research Institute of Navarra (IdiSNA), Pamplona, Spain |
| authorships[31].institutions[0].id | https://openalex.org/I4210135003 |
| authorships[31].institutions[0].ror | https://ror.org/03phm3r45 |
| authorships[31].institutions[0].type | healthcare |
| authorships[31].institutions[0].lineage | https://openalex.org/I4210135003 |
| authorships[31].institutions[0].country_code | ES |
| authorships[31].institutions[0].display_name | Clinica Universidad de Navarra |
| authorships[31].institutions[1].id | https://openalex.org/I4210112085 |
| authorships[31].institutions[1].ror | https://ror.org/023d5h353 |
| authorships[31].institutions[1].type | education |
| authorships[31].institutions[1].lineage | https://openalex.org/I4210112085 |
| authorships[31].institutions[1].country_code | ES |
| authorships[31].institutions[1].display_name | Navarre Institute of Health Research |
| authorships[31].institutions[2].id | https://openalex.org/I88155538 |
| authorships[31].institutions[2].ror | https://ror.org/02rxc7m23 |
| authorships[31].institutions[2].type | education |
| authorships[31].institutions[2].lineage | https://openalex.org/I88155538 |
| authorships[31].institutions[2].country_code | ES |
| authorships[31].institutions[2].display_name | Universidad de Navarra |
| authorships[31].author_position | middle |
| authorships[31].raw_author_name | Ana Patiño-García |
| authorships[31].is_corresponding | False |
| authorships[31].raw_affiliation_strings | Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain, Health Research Institute of Navarra (IdiSNA), Pamplona, Spain, Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[32].author.id | https://openalex.org/A5043314436 |
| authorships[32].author.orcid | https://orcid.org/0000-0003-0432-3133 |
| authorships[32].author.display_name | Fernando Pastor |
| authorships[32].countries | ES |
| authorships[32].affiliations[0].institution_ids | https://openalex.org/I88155538 |
| authorships[32].affiliations[0].raw_affiliation_string | Molecular Therapeutics Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[32].institutions[0].id | https://openalex.org/I88155538 |
| authorships[32].institutions[0].ror | https://ror.org/02rxc7m23 |
| authorships[32].institutions[0].type | education |
| authorships[32].institutions[0].lineage | https://openalex.org/I88155538 |
| authorships[32].institutions[0].country_code | ES |
| authorships[32].institutions[0].display_name | Universidad de Navarra |
| authorships[32].author_position | middle |
| authorships[32].raw_author_name | Fernando Pastor |
| authorships[32].is_corresponding | False |
| authorships[32].raw_affiliation_strings | Molecular Therapeutics Program, CIMA-Universidad de Navarra, Pamplona, Spain |
| authorships[33].author.id | https://openalex.org/A5005329272 |
| authorships[33].author.orcid | https://orcid.org/0000-0002-7520-7351 |
| authorships[33].author.display_name | Marta M. Alonso |
| authorships[33].countries | CH |
| authorships[33].affiliations[0].institution_ids | https://openalex.org/I202697423 |
| authorships[33].affiliations[0].raw_affiliation_string | Zurich Open Repository and Archive University of Zurich University Library Strickhofstrasse 39 CH-8057 Zurich |
| authorships[33].institutions[0].id | https://openalex.org/I202697423 |
| authorships[33].institutions[0].ror | https://ror.org/02crff812 |
| authorships[33].institutions[0].type | education |
| authorships[33].institutions[0].lineage | https://openalex.org/I202697423 |
| authorships[33].institutions[0].country_code | CH |
| authorships[33].institutions[0].display_name | University of Zurich |
| authorships[33].author_position | last |
| authorships[33].raw_author_name | Marta M. Alonso |
| authorships[33].is_corresponding | True |
| authorships[33].raw_affiliation_strings | Zurich Open Repository and Archive University of Zurich University Library Strickhofstrasse 39 CH-8057 Zurich |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://ars.els-cdn.com/content/image/1-s2.0-S1535610823003185-fx1_lrg.jpg |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12387 |
| primary_topic.field.id | https://openalex.org/fields/24 |
| primary_topic.field.display_name | Immunology and Microbiology |
| primary_topic.score | 0.998199999332428 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2403 |
| primary_topic.subfield.display_name | Immunology |
| primary_topic.display_name | Galectins and Cancer Biology |
| related_works | https://openalex.org/W2263980547, https://openalex.org/W4361271945, https://openalex.org/W2085972006, https://openalex.org/W3166800855, https://openalex.org/W3197188017, https://openalex.org/W4200507838, https://openalex.org/W2911915410, https://openalex.org/W2575161424, https://openalex.org/W3029432090, https://openalex.org/W2277229875 |
| cited_by_count | 74 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 35 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 34 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 5 |
| locations_count | 5 |
| best_oa_location.id | doi:10.1016/j.ccell.2023.09.001 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S25671836 |
| best_oa_location.source.issn | 1535-6108, 1878-3686 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1535-6108 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Cancer Cell |
| best_oa_location.source.host_organization | https://openalex.org/P4310315673 |
| best_oa_location.source.host_organization_name | Cell Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310315673, https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_lineage_names | Cell Press, Elsevier BV |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | https://ars.els-cdn.com/content/image/1-s2.0-S1535610823003185-fx1_lrg.jpg |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Cancer Cell |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.ccell.2023.09.001 |
| primary_location.id | doi:10.1016/j.ccell.2023.09.001 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S25671836 |
| primary_location.source.issn | 1535-6108, 1878-3686 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1535-6108 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Cancer Cell |
| primary_location.source.host_organization | https://openalex.org/P4310315673 |
| primary_location.source.host_organization_name | Cell Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310315673, https://openalex.org/P4310320990 |
| primary_location.source.host_organization_lineage_names | Cell Press, Elsevier BV |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | https://ars.els-cdn.com/content/image/1-s2.0-S1535610823003185-fx1_lrg.jpg |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Cancer Cell |
| primary_location.landing_page_url | https://doi.org/10.1016/j.ccell.2023.09.001 |
| publication_date | 2023-10-05 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W3174246647, https://openalex.org/W2420857723, https://openalex.org/W2802016878, https://openalex.org/W2751187578, https://openalex.org/W2973200220, https://openalex.org/W2059060292, https://openalex.org/W2889803667, https://openalex.org/W2810219671, https://openalex.org/W2889354357, https://openalex.org/W2013177587, https://openalex.org/W2797220908, https://openalex.org/W2919077749, https://openalex.org/W6649426660, https://openalex.org/W1965993410, https://openalex.org/W3168169234, https://openalex.org/W2145024411, https://openalex.org/W2911827977, https://openalex.org/W2005158904, https://openalex.org/W2029562865, https://openalex.org/W2089006429, https://openalex.org/W4292231180, https://openalex.org/W2789744717, https://openalex.org/W4304161032, https://openalex.org/W6751548998, https://openalex.org/W4311585488, https://openalex.org/W3040044015, https://openalex.org/W4281491144, https://openalex.org/W4293103602, https://openalex.org/W2808897147, https://openalex.org/W4283727701, https://openalex.org/W3128442351, https://openalex.org/W2917772140, https://openalex.org/W1560092366, https://openalex.org/W3181404157, https://openalex.org/W2767198352, https://openalex.org/W2996809166, https://openalex.org/W3015150584, https://openalex.org/W4225081365, https://openalex.org/W2803040262, https://openalex.org/W2947508497, https://openalex.org/W4223619625, https://openalex.org/W4210924686, https://openalex.org/W3011904611, https://openalex.org/W3008346199, https://openalex.org/W3047765583, https://openalex.org/W3037497912, https://openalex.org/W4223498518, https://openalex.org/W2791700208, https://openalex.org/W3094045806, https://openalex.org/W3026345469, https://openalex.org/W2059443686, https://openalex.org/W3186005391, https://openalex.org/W2982017357, https://openalex.org/W2797866384, https://openalex.org/W3214936723, https://openalex.org/W3048665145, https://openalex.org/W2802053370, https://openalex.org/W4306795470, https://openalex.org/W2112400160, https://openalex.org/W1996032846 |
| referenced_works_count | 60 |
| abstract_inverted_index.a | 112, 117, 127 |
| abstract_inverted_index.In | 31 |
| abstract_inverted_index.To | 19 |
| abstract_inverted_index.We | 58 |
| abstract_inverted_index.an | 6 |
| abstract_inverted_index.as | 126 |
| abstract_inverted_index.by | 87 |
| abstract_inverted_index.in | 45, 56, 64, 94, 131 |
| abstract_inverted_index.is | 5, 42, 85 |
| abstract_inverted_index.of | 15, 62, 67, 76, 91, 100, 108 |
| abstract_inverted_index.we | 34 |
| abstract_inverted_index.and | 11, 49, 54, 71, 105, 133 |
| abstract_inverted_index.for | 28 |
| abstract_inverted_index.its | 135 |
| abstract_inverted_index.the | 12, 26, 37, 88, 97, 106 |
| abstract_inverted_index.DIPG | 68, 132 |
| abstract_inverted_index.This | 82, 122 |
| abstract_inverted_index.bona | 128 |
| abstract_inverted_index.both | 46 |
| abstract_inverted_index.cell | 103 |
| abstract_inverted_index.fide | 129 |
| abstract_inverted_index.free | 75 |
| abstract_inverted_index.need | 27 |
| abstract_inverted_index.show | 59 |
| abstract_inverted_index.stem | 9 |
| abstract_inverted_index.that | 36, 60, 78, 110 |
| abstract_inverted_index.this | 32 |
| abstract_inverted_index.work | 123 |
| abstract_inverted_index.DIPG. | 57 |
| abstract_inverted_index.TIM-3 | 40, 63, 92, 125 |
| abstract_inverted_index.brain | 8 |
| abstract_inverted_index.cause | 14 |
| abstract_inverted_index.cells | 48 |
| abstract_inverted_index.date, | 20 |
| abstract_inverted_index.these | 21 |
| abstract_inverted_index.tumor | 10, 47, 95, 114 |
| abstract_inverted_index.(DIPG) | 4 |
| abstract_inverted_index.action | 99 |
| abstract_inverted_index.cells, | 51, 96 |
| abstract_inverted_index.create | 111 |
| abstract_inverted_index.death. | 18 |
| abstract_inverted_index.direct | 89 |
| abstract_inverted_index.driven | 86 |
| abstract_inverted_index.effect | 84, 90 |
| abstract_inverted_index.glioma | 3 |
| abstract_inverted_index.harbor | 79 |
| abstract_inverted_index.highly | 43 |
| abstract_inverted_index.immune | 38, 80, 102, 120 |
| abstract_inverted_index.mainly | 52 |
| abstract_inverted_index.models | 66 |
| abstract_inverted_index.potent | 118 |
| abstract_inverted_index.remain | 23 |
| abstract_inverted_index.study, | 33 |
| abstract_inverted_index.target | 130 |
| abstract_inverted_index.tumors | 22 |
| abstract_inverted_index.Diffuse | 0 |
| abstract_inverted_index.disease | 77 |
| abstract_inverted_index.leading | 13 |
| abstract_inverted_index.memory. | 81 |
| abstract_inverted_index.pontine | 2 |
| abstract_inverted_index.several | 101 |
| abstract_inverted_index.(HAVCR2) | 41 |
| abstract_inverted_index.clinical | 136 |
| abstract_inverted_index.favoring | 116 |
| abstract_inverted_index.produces | 72 |
| abstract_inverted_index.prolongs | 69 |
| abstract_inverted_index.supports | 134 |
| abstract_inverted_index.survival | 70 |
| abstract_inverted_index.uncovers | 124 |
| abstract_inverted_index.antitumor | 83, 119 |
| abstract_inverted_index.expressed | 44 |
| abstract_inverted_index.intrinsic | 1 |
| abstract_inverted_index.long-term | 73 |
| abstract_inverted_index.microglia | 53 |
| abstract_inverted_index.pediatric | 16 |
| abstract_inverted_index.response. | 121 |
| abstract_inverted_index.secretion | 107 |
| abstract_inverted_index.survivors | 74 |
| abstract_inverted_index.syngeneic | 65 |
| abstract_inverted_index.aggressive | 7 |
| abstract_inverted_index.checkpoint | 39 |
| abstract_inverted_index.incurable, | 24 |
| abstract_inverted_index.inhibition | 61, 93 |
| abstract_inverted_index.therapies. | 30 |
| abstract_inverted_index.coordinated | 98 |
| abstract_inverted_index.demonstrate | 35 |
| abstract_inverted_index.efficacious | 29 |
| abstract_inverted_index.macrophages, | 55 |
| abstract_inverted_index.populations, | 104 |
| abstract_inverted_index.translation. | 137 |
| abstract_inverted_index.underscoring | 25 |
| abstract_inverted_index.cancer-related | 17 |
| abstract_inverted_index.proinflammatory | 113 |
| abstract_inverted_index.microenvironment | 115 |
| abstract_inverted_index.microenvironmental | 50 |
| abstract_inverted_index.chemokines/cytokines | 109 |
| cited_by_percentile_year.max | 100 |
| cited_by_percentile_year.min | 97 |
| corresponding_author_ids | https://openalex.org/A5005329272 |
| countries_distinct_count | 4 |
| institutions_distinct_count | 34 |
| corresponding_institution_ids | https://openalex.org/I202697423 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8600000143051147 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.99242806 |
| citation_normalized_percentile.is_in_top_1_percent | True |
| citation_normalized_percentile.is_in_top_10_percent | True |